24 HR nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q]
RxNorm concept 351427, branded drug (sbd). Prescribable name: NICODERM CQ (Step 2) 14 MG/Day 24HR Transdermal System.
- RxCUI
- 351427
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/351427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
24 HR Nicoderm C-Q 0.583 MG/HR Transdermal System; NICODERM CQ (Step 2) 14 MG/Day 24HR Transdermal System; Nicoderm C-Q 0.583 MG/HR 24HR Transdermal Patch; Nicoderm CQ (Step 2) 14 MG/Day 24HR Transdermal Patch
Related concepts
- nicotine 0.583 MG/HR (SCDC, consists of)
- nicotine 0.583 MG/HR [Nicoderm C-Q] (SBDC, consists of)
- Transdermal System (DF, has dose form)
- Nicoderm C-Q (BN, has ingredient)
- 24 HR nicotine 0.583 MG/HR Transdermal System (SCD, tradename of)
Linked data
NDCs
- 00135019502
- 00135019503
- 00135019505
- 00135019508
- 00766143020
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 351427 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/351427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 351427. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.